Xiaojue Wang

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Coordinated DNA 5-mC and RNA m5C methylation epigenetically regulates MZF1 splice variants to drive EGFR-TKI resistance.

Coordinated DNA 5-mC and RNA m5C methylation epigenetically regulates MZF1 splice variants to drive EGFR-TKI resistance.

Journal: Experimental & molecular medicine

Published: November 24, 2025

Soluble programmed cell death ligand-1 as a predictive biomarker for severity and poor prognosis in pulmonary tuberculosis.

Soluble programmed cell death ligand-1 as a predictive biomarker for severity and poor prognosis in pulmonary tuberculosis.

Journal: Annals of medicine

Published: July 10, 2025

Epigenetic Insights Into Aging: Emerging Roles of Natural Products in Therapeutic Interventions.

Epigenetic Insights Into Aging: Emerging Roles of Natural Products in Therapeutic Interventions.

Journal: Phytotherapy research : PTR

Published: February 12, 2025

Epigenetic regulators combined with tumour immunotherapy: current status and perspectives.

Epigenetic regulators combined with tumour immunotherapy: current status and perspectives.

Journal: Clinical epigenetics

Published: December 31, 2024

CD8+ T cells infiltrating into tumors were controlled by immune status of pulmonary lymph nodes and correlated with non-small cell lung cancer (NSCLC) patients' prognosis treated with chemoimmunotherapy.

CD8+ T cells infiltrating into tumors were controlled by immune status of pulmonary lymph nodes and correlated with non-small cell lung cancer (NSCLC) patients' prognosis treated with chemoimmunotherapy.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 14, 2024

Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.

Cancer-associated fibroblasts: heterogeneity and their role in the tumor immune response.

Journal: Clinical and experimental medicine

Published: February 11, 2024

Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands.

Establishment of novel anti-TIM-3 antibodies interfering with its binding to ligands.

Journal: Heliyon

Published: October 24, 2023

The levels of soluble CD137 are increased in tuberculosis patients and associated with disease severity and prognosis.

The levels of soluble CD137 are increased in tuberculosis patients and associated with disease severity and prognosis.

Journal: European journal of immunology

Published: September 29, 2023

Immunoassay with Novel Paired Antibodies for Detection of Lipoarabinomannan in the Pleural Fluid and Plasma of Patients with Tuberculous Pleurisy.

Immunoassay with Novel Paired Antibodies for Detection of Lipoarabinomannan in the Pleural Fluid and Plasma of Patients with Tuberculous Pleurisy.

Journal: Microorganisms

Published: July 20, 2023

Costimulatory capacity of CD137 mAbs on T cells depends on elaborate CRD structures but not on blocking ligand-receptor binding.

Costimulatory capacity of CD137 mAbs on T cells depends on elaborate CRD structures but not on blocking ligand-receptor binding.

Journal: European journal of immunology

Published: March 18, 2023

Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC.

Association between response to anti-PD-1 treatment and blood soluble PD-L1 and IL-8 changes in patients with NSCLC.

Journal: Discover oncology

Published: February 04, 2023

PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer.

PCSK9 regulates the efficacy of immune checkpoint therapy in lung cancer.

Journal: Frontiers in immunology

Published: January 11, 2023

Showing 1-12 of 24

Last Updated: 09/26/2026